HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes
- PMID: 15172443
- DOI: 10.1016/j.humimm.2004.02.001
HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes
Abstract
Natural killer (NK)-cytotoxic T lymphocytes (CTL) are a subset of CD8(+) cytolytic T lymphocytes that express human leukocyte antigen (HLA) class I-specific inhibitory receptors. They are detectable as monoclonal expansions in the blood of cytomegalovirus (CMV)-seropositive individuals displaying particular HLA-Cw allotypes. Similar to NK cells, they are capable of killing various allogeneic tumor cell lines, a function referred to as "NK-like activity." The mechanism underlying this unusual functional property has recently been clarified. Via their T-cell receptor, NK-CTL recognize the nonclassical HLA class I molecule HLA-E, which is characterized by a limited polymorphism and by the ability to bind peptides derived from the leader sequence of various HLA class I alleles as well as from few viral proteins. The analysis of the T-cell receptor avidity revealed that NK-CTL recognize with high avidity a CMV UL40-derived peptide. The HLA-E-restricted recognition of CMV by NK-CTL may represent an important immunologic strategy in defenses against this virus. Indeed, unlike conventional CTL, NK-CTL mediated lysis is apparently not affected by the downregulation of major histocompatibility complex class I that occurs during CMV infection. Because the CMV UL40-derived peptide is identical to the one generated from the leader sequence of various HLA-Cw alleles, NK-CTL are also able to display an "HLA-E-dependent alloreactivity" against allogeneic target cells expressing appropriate HLA-Cw alleles. This broad ability to recognize and kill allogeneic cells may pose serious problems in transplantation.
Similar articles
-
Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion.Eur J Immunol. 2005 Nov;35(11):3240-7. doi: 10.1002/eji.200535343. Eur J Immunol. 2005. PMID: 16224817
-
Human T cell receptor-mediated recognition of HLA-E.Eur J Immunol. 2002 Apr;32(4):936-44. doi: 10.1002/1521-4141(200204)32:4<936::AID-IMMU936>3.0.CO;2-M. Eur J Immunol. 2002. PMID: 11920559
-
The analysis of the natural killer-like activity of human cytolytic T lymphocytes revealed HLA-E as a novel target for TCR alpha/beta-mediated recognition.Eur J Immunol. 2001 Dec;31(12):3687-93. doi: 10.1002/1521-4141(200112)31:12<3687::aid-immu3687>3.0.co;2-c. Eur J Immunol. 2001. PMID: 11745389
-
NK-CTLs, a novel HLA-E-restricted T-cell subset.Trends Immunol. 2003 Mar;24(3):136-43. doi: 10.1016/s1471-4906(03)00031-0. Trends Immunol. 2003. PMID: 12615209 Review. No abstract available.
-
Enhancing Natural Killer and CD8+ T Cell-Mediated Anticancer Cytotoxicity and Proliferation of CD8+ T Cells with HLA-E Monospecific Monoclonal Antibodies.Monoclon Antib Immunodiagn Immunother. 2019 Apr;38(2):38-59. doi: 10.1089/mab.2018.0043. Monoclon Antib Immunodiagn Immunother. 2019. PMID: 31009335 Free PMC article. Review.
Cited by
-
Characteristics of HLA-E Restricted T-Cell Responses and Their Role in Infectious Diseases.J Immunol Res. 2016;2016:2695396. doi: 10.1155/2016/2695396. Epub 2016 Sep 6. J Immunol Res. 2016. PMID: 27699181 Free PMC article. Review.
-
CD94-NKG2A recognition of human leukocyte antigen (HLA)-E bound to an HLA class I leader sequence.J Exp Med. 2008 Mar 17;205(3):725-35. doi: 10.1084/jem.20072525. Epub 2008 Mar 10. J Exp Med. 2008. PMID: 18332182 Free PMC article.
-
Various hypotheses on MHC evolution suggested by the concerted evolution of CD94L and MHC class Ia molecules.Biol Direct. 2006 Jan 31;1:3. doi: 10.1186/1745-6150-1-3. Biol Direct. 2006. PMID: 16542034 Free PMC article.
-
Antigen presentation and the ubiquitin-proteasome system in host-pathogen interactions.Adv Immunol. 2006;92:225-305. doi: 10.1016/S0065-2776(06)92006-9. Adv Immunol. 2006. PMID: 17145306 Free PMC article. Review.
-
HLA-E-restricted HIV-1-specific CD8+ T cell responses in natural infection.J Clin Invest. 2021 Aug 16;131(16):e148979. doi: 10.1172/JCI148979. J Clin Invest. 2021. PMID: 34228645 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials